Monoclonal antibodies — a proven and rapidly expanding therapeutic modality for human diseases

Overview of attention for article published in Protein & Cell, April 2010

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (72nd percentile)
Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

patent: 3 patents

Citations

dimensions_citation: 51 Dimensions

Readers on

mendeley: 142 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 3 patents that reference this research output.

Influenza A virus specific antibodies

Application US-9718874-B2

United States of America

HUMANIZED ANTI-IgE ANTIBODIES THAT CROSSLINK CD23 ON B LYMPHOCYTES BUT DO NOT SENSITIZE…

Application WO-2015195631-A1

World Intellectual Property Organisation (WIPO)

Gpr177 as target and marker in tumors

Grant US-9062114-B2

United States of America